710 West 168th Street, 3rd floor
Clinical Trials Currently Enrolling Participants
Citalopram for Agitation in Alzheimer's Disease (CitAD)
This is a research study, funded by the NIH, for people ages 50-99 who have Alzheimer's Disease and also have symptoms of agitation and/or aggression. The study includes medical evaluation by physicians who specialize in memory disorders and treatment with medication. Each eligible participant must have a family member or caregiver who can provide information during the research study.
Website information at: http://clinicaltrials.gov/ct2/show/NCT00898807.
For more information, please contact Corazon de la Pena at (212) 543-6132.
Early symptoms of Frontotemporal Lobar Degeneration
This research study seeks to evaluate the earliest signs of Frontotemporal Lobar Degeneration and whether lifestyle can modify the progression of the disease. This study is seeking volunteers from families in whom at least one member has a confirmed MAPT mutation of FTLD (also known as the "tau" gene).
For more information, please contact Gayathri Cheran, at 212-305-1561 or email@example.com
ENROLL-HD is a world-wide initiative to learn more information about Huntington's disease by evaluating individuals who are part of an HD family. Ultimately, information learned from this study may help in the development of future experimental drug studies aimed at slowing or postponing HD disease onset and progression. All individuals diagnosed with HD, and individuals age 18 and older from an HD family, regardless of genetic testing status are eligible to participate.Â
For more information, please contact Paula Wasserman at (212) 305-4597 or email firstname.lastname@example.org.
In this observational study, people with a diagnosis of Huntington's disease or at-risk for Huntington's disease are asked to perform three motor tasks: grasping an object, tapping on a computer keyboard and walking. The purpose of this study is to learn more about motor and functional changes in individuals with HD. The study visit will take approximately 1.5 hours, once every year for three years.Â
For more information, please contact Dr. Ashwini Rao at (212) 305-1647.
Ameliorating age-related memory decline
In this study we are testing whether exercise or a derivative of chocolate ameliorates memory decline that occurs with aging. Individuals who are 55 years old and older are eligible.
For more information, please contact Scott Small (212) 305-1269.
Alzheimer's Disease Neuroimaging Initiative (ADNI-2)
This purpose of this study is to determine if brain imaging can help predict the onset and monitor the progression of Alzheimer's disease. The study will also use lumbar punctures and blood draws to determine if biomarkers can predict and monitor the disease. English and Spanish speaking people with memory complaints who are in good general health and between the ages of 55 and 90 may be eligible to participate.
For more information, please contact PhilipYeung: (212) 342-0522.
African American Genetics Study
The purpose of this study is to look at genetic risk factors for Alzheimer's disease among African Americans for people over the age of 60. The study involves an interview consisting of memory and thinking tests, questions about your heath and experiences, and a blood draw.
For more information, please contact Steven Philemond (212) 305-1893.
Late Onset Alzheimer Disease Study (LOAD)
The purpose of this study is to identify genes that may increase the risk for developing Alzheime's disease (AD). We are seeking families with at least two living siblings diagnosed with AD who are 60 years or older.
For more information, please contact Pedro Mena (212) 305-2309.
Dominantly Inherited Alzheimer Network (DIAN)
The main objective of this study is to learn about brain changes that may occur on people who carry a genetic mutation which causes early onset Alzheimer disease. These participants will receive an annual follow up before they present any symptoms and includes evaluations, mental status testing, MRI and PET scans, blood assays with genetic studies and assays of cerebrospinal fluids.
For more information, please contact Dolly Reyes-Dumeyer (212) 305-5953.
The study of Alzheimer Disease in Caribbean Hispanic Families
The purpose of this study is to identify genes that may increase the risk for developing Alzheime's disease (AD). We are seeking families and/or individuals who are 60 years or older, with or without memory problems.
For more information, please contact Angel Piriz (212) 305-2309.
Antidepressant Treatment Studies for Combined Depression and Memory Complaints
We are conducting medication treatment research studies for individuals age 55+ with both depression and mild memory and/or concentration difficulties. The studies offer neuropsychological testing for memory and psychiatric evaluation of mood. Treatment is provided for eligible individuals at no cost for at least 6 months.
For more information, please contact Kristina D’Antonio (212) 543-5956.
Genetic Linkage Study
We are seeking families of all nationalities and backgrounds for a study that seeks to identify genes that may increase the risk for developing Alzheimer's disease (AD). If your family has at least two living siblings diagnosed with AD who are 60 years old or older.
For more information, please contact Amanda Sena at (212) 305-5097.
Brain donation allows valuable information to be obtained regarding normal aging and diseases that affect memory. This information may be useful towards the goal of developing more effective treatment strategies. If you or a family member wish to learn more about this program.
For more information, please contact Arlene Lawton, RN at (212) 305-9086.
Changes in memory and thinking abilities can occur from a variety of conditions, not just Alzheimer’s disease.Taub Institute specialists offer a thorough multidisciplinary evaluation of memory and thinking difficulties. We are located at The Neurological Institute, Columbia University Medical Center, 710 West 168th Street, New York.
For appointments, please call (212) 305-6939.